Abiopharma

Gain Therapeutics to Participate in Upcoming Investor Conferences

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S

X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA

Arcutis Enrolls First Child in INTEGUMENT-INFANT EvaluatingZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS

TruBridge, Inc.: TruBridge Announces Participation in the Truist Securities Healthcare Disruptors & Digital Health Conference

Masimo - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia